Objective To investigate the clinical and pathological features of cryptogenic liver cancer,and to determine its etiology and pathogenesis. Methods A total of 22 patients with cryptogenic liver cancer who underwent surgical treatment in China- Japan Union Hospital of Jilin University from January 2010 to December 2015 were enrolled,and their clinical and pathological data were analyzed. Results The mean age of these patients was 57 years,and the male / female ratio was 1. 7 ∶ 1. Sixteen patients( 72. 7%) were complicated by fatty liver disease,and 13 patients( 59. 1%) had clinical symptoms such as abdominal pain and abdominal distension. The dominant abnormalities in biochemical examinations were increases in alkaline phosphatase and / or gamma- glutamyl transpeptidase,which occurred in 14 patients( 63. 6%). The results of pathological examination showed that 16 patients( 72. 7%) had cholangiocellular carcinoma,20( 90. 9%)had a single tumor,14( 63. 6%) had a tumor diameter of < 5 cm,4( 18. 2%) had local invasion,and 2( 9. 1%) had vessel invasion.The immunohistochemical results revealed 19 Ki67- positive patients,13 CK17- positive patients,and 16 CK19- positive patients. Conclusion The analyses of the clinical and pathological features of cryptogenic liver cancer confirm that nonalcoholic steatohepatitis( NASH)is one of the major pathogenic factors for cryptogenic liver cancer,and most liver cancer cases caused by NASH are single adenocarcinoma.
[1]BOSETTI C,TURATI F,La VECCHIA C.Hepatocellular carcinoma epidemiology[J].Best Pract Res Clin Gastroenterol,2014,28(5):753-770.
|
[2]FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):e359-e386.
|
[3]HSU CY,LEE YH,LIU PH,et al.Decrypting cryptogenic hepatocellular carcinoma:clinical manifestations,prognostic factors and long-term survival by propensity score model[J].PLoS One,2014,9(2):e89373.
|
[4]YOSHITAKA T,KAZUHIRO N.Nonalcoholic steatohepatitis-associated hepatocellular carcinoma:our case series and literature review[J].World J Gastroenterol,2010,16(12):1436-1441.
|
[5]ERTLE J,DECHENE A,SOWA JP,et al.Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis[J].Int J Cancer,2011,128(10):2436-2443.
|
[6]SIRIWARDANA RC,NIRIELLA MA,LIYANAGE CA,et al.Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka[J].Indian J Gastroenterol,2013,32(6):397-399.
|
[7]REDDY SK,STEEL JL,CHEN HW,et al.Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease[J].Hepatology,2012,55(6):1809-1819.
|
[8]KOIKE K.Hepatitis B virus HBx gene and hepatocarcinogenesis[J].Intervirology,1995,38(3-4):134-142.
|
[9]NAGATA M,SUZUKI W,IIZUKA S,et al.Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate[J].Exp Anim,2006,55(2):109-115.
|
[10]ROSMORDUC O,FARTOUX L.HCC and NASH:how strong is the clinical demonstration?[J].Clin Res Hepatol Gastroenterol,2012,36(3):202-208.
|
[11]PAGE JM,HARRISON SA.NASH and HCC[J].Clin Liver Dis,2009,13(4):631-647.
|
[12]CHEN JG,LU JH,ZHU YR,et al.A thirty-one year prospective follow-up program on the HBsA g carrier state and primary liver cancer in Qidong,China[J].Chin J Epidemiol,2010,31(7):721-726.(in Chinese)陈建国,陆建华,朱源荣,等.乙型肝炎病毒感染与肝癌发生的31年随访研究[J].中华流行病学杂志,2010,31(7):721-726.
|
[13]SIRIWARDANA RC,NIRIELLA MA,DASSANAYAKE AS,et al.Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis:a prospective study[J].Hepatobiliary Pancreat Dis Int,2015,14(4):401-405.
|
[14]KAO WY,SU CW,CHAU GY,et al.A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery[J].World J Surg,2011,35(4):858-867.
|
[15]ARNDT W,YVONNE A,SANDRA K,et al.Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma[J].BMC Cancer,2015,15:210.
|